CN107135645A - 用于在伤口愈合中使用的植物提取物和化合物 - Google Patents

用于在伤口愈合中使用的植物提取物和化合物 Download PDF

Info

Publication number
CN107135645A
CN107135645A CN201580073703.XA CN201580073703A CN107135645A CN 107135645 A CN107135645 A CN 107135645A CN 201580073703 A CN201580073703 A CN 201580073703A CN 107135645 A CN107135645 A CN 107135645A
Authority
CN
China
Prior art keywords
tanshinone
salvia
compounds
plant extracts
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580073703.XA
Other languages
English (en)
Chinese (zh)
Inventor
A·B·加拉格尔
R·W·哈特曼
M·恩格尔
A·科克
C·J·范柯鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phynova Ltd
Original Assignee
Phynova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phynova Ltd filed Critical Phynova Ltd
Publication of CN107135645A publication Critical patent/CN107135645A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6955—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a plaster, a bandage, a dressing or a patch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
CN201580073703.XA 2014-12-03 2015-11-30 用于在伤口愈合中使用的植物提取物和化合物 Pending CN107135645A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1421479.5A GB201421479D0 (en) 2014-12-03 2014-12-03 A plant extract and compounds for use in wound healing
GB1421479.5 2014-12-03
PCT/GB2015/000312 WO2016087810A1 (en) 2014-12-03 2015-11-30 A plant extract and compounds for use in wound healing

Publications (1)

Publication Number Publication Date
CN107135645A true CN107135645A (zh) 2017-09-05

Family

ID=52349874

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580073703.XA Pending CN107135645A (zh) 2014-12-03 2015-11-30 用于在伤口愈合中使用的植物提取物和化合物

Country Status (6)

Country Link
US (1) US20180228858A1 (https=)
EP (1) EP3226879A1 (https=)
JP (1) JP6829691B2 (https=)
CN (1) CN107135645A (https=)
GB (2) GB201421479D0 (https=)
WO (1) WO2016087810A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110251716A (zh) * 2019-04-22 2019-09-20 张贤慧 一种伤口护理用凝胶敷料及其制备方法
TWI750705B (zh) * 2020-06-19 2021-12-21 慈濟學校財團法人慈濟大學 預防及/或治療壓力誘發疾病之方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102687221B1 (ko) * 2016-12-05 2024-07-22 주식회사 엘지생활건강 디하이드로탄시논 ⅰ을 포함하는 구강질환 예방 또는 치료용 조성물
US20210393585A1 (en) * 2020-06-19 2021-12-23 Tzu Chi University Method for preventing and/or treating a stress-induced disease

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056285C (zh) * 1993-02-10 2000-09-13 伊塞哈根药材经营股份有限公司 含有鼠尾草花提取物的药物
CN101119726A (zh) * 2005-02-16 2008-02-06 Md白奥阿尔法有限公司 用于治疗或预防涉及肥胖、糖尿病、代谢综合症、神经变性疾病和线粒体功能障碍疾病的疾病的药物组合物
CN101411745A (zh) * 2007-10-15 2009-04-22 博仲盛景医药技术（北京）有限公司 一种抗菌丹参酮提取物、其制备方法、用途及其产品
CN101642486A (zh) * 2009-08-28 2010-02-10 湖南省中医药研究院 一种促进创伤愈合的中药组合物及其制备方法
JP2010106001A (ja) * 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤
CN103705616A (zh) * 2014-01-02 2014-04-09 魏春战 一种祛腐生肌膏的配方
CN103830175A (zh) * 2012-11-26 2014-06-04 青岛百草汇中草药研究所 含有丹参酮的乳剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163319A (ja) * 1983-03-07 1984-09-14 Sawai Seiyaku Kk 抗真菌剤
JPH0830077B2 (ja) * 1987-04-24 1996-03-27 晟 八木 虚血性疾患治療剤
KR100861186B1 (ko) * 2001-03-26 2008-09-30 주식회사 엘지생활건강 크립토탄시논을 함유하는 여드름 예방 및 치료용 화장료
EP1706108A4 (en) * 2003-12-30 2009-08-12 Md Bioalpha Co Ltd TREATMENT OF FAT AND METABOLIC SYNDROME WITH TRANSHINONE DERIVATIVES FOR INCREASING METABOLISM ACTIVITY
KR100725839B1 (ko) * 2005-10-06 2007-12-11 일성신약주식회사 단삼으로부터 분리된 탄시논류의 화합물을 함유하는인지기능 장애의 예방 및 치료용 조성물
CN102579650B (zh) * 2011-03-10 2014-02-26 成都中医药大学 一种预防或/和治疗压疮的药物组合物及其制备方法和用途
CN102727581B (zh) * 2011-04-11 2016-02-10 苏州瑞美科生物技术有限公司 一种对伤口具有修复作用的药物组合物
CN103356844B (zh) * 2012-03-28 2015-12-16 苏州瑞美科生物技术有限公司 一种低聚壳聚糖复方制剂及其在制备治疗皮肤疾病的药物中应用
CN102824599B (zh) * 2012-08-07 2013-12-25 孟庆德 一种治疗糖尿病引起的各种皮肤溃烂的中药酊剂
CN102988370A (zh) * 2012-11-23 2013-03-27 广东省中医院 丹参酮i在制备治疗银屑病药物中的应用
CN103040956A (zh) * 2013-01-18 2013-04-17 江其生 一种能预防和治疗皮肤放射损伤的中药组合物
CN103230493B (zh) * 2013-04-15 2015-04-22 杨少辉 一种治疗创口不愈的中药组合物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056285C (zh) * 1993-02-10 2000-09-13 伊塞哈根药材经营股份有限公司 含有鼠尾草花提取物的药物
CN101119726A (zh) * 2005-02-16 2008-02-06 Md白奥阿尔法有限公司 用于治疗或预防涉及肥胖、糖尿病、代谢综合症、神经变性疾病和线粒体功能障碍疾病的疾病的药物组合物
CN101411745A (zh) * 2007-10-15 2009-04-22 博仲盛景医药技术（北京）有限公司 一种抗菌丹参酮提取物、其制备方法、用途及其产品
JP2010106001A (ja) * 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤
CN101642486A (zh) * 2009-08-28 2010-02-10 湖南省中医药研究院 一种促进创伤愈合的中药组合物及其制备方法
CN103830175A (zh) * 2012-11-26 2014-06-04 青岛百草汇中草药研究所 含有丹参酮的乳剂及其制备方法
CN103705616A (zh) * 2014-01-02 2014-04-09 魏春战 一种祛腐生肌膏的配方

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
GUIXIANG REN，等: "Screening and evaluation of traditional Chinese medicine by microarray expression analysis", 《JOURNAL OF ETHNOPHARMACOLOGY》 *
IPEK SUNTAR，等: "Investigating wound healing，tyrosinase inhibitory and antioxidant activities of the ethanol extracts of Salvia cryptantha and Salvia cyanescens using in vivo and in vitro experimental models", 《JOURNAL OF ETHNOPHARMACOLOGY》 *
JULIETTE EMMERICH，等: "Cushing’s Syndrome：Development of Highly Potent and Selective CYP11B1 Inhibitors of the （Pyridylmethyl）pyridine Type", 《JOURNAL OF MEDICINAL CHEMISTRY》 *
SASA VUKELIC: "Cortisol Synthesis in Epidermis Is Induced by IL-1 and Tissue Injury", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 *
WEIPENG BIAN，等: "Dihydrotanshinone I inhibits angiogenesis both in vitro and in vivo", 《ACTA BIOCHIM BIOPHYS SIN》 *
YAQING TAN，等: "Ectopic expression of human acidic fibroblast growth factor 1 in the medicinal plant，Salvia miltiorrhiza，accelerates the healing of burn wounds", 《BMC BIOTECHNOLOGY》 *
YUE-MIN XU,等: "THE VALUE OF ADRENAL AUTOTRANSPLANTATION WITH ATTACHED BLOOD VESSELS FOR THE TREATMENT OF CUSHING’S DISEASE：A PRELIMINARY REPORT", 《THE JOURNAL OF UROLOGY》 *
张逸等: "丹参促进烧伤创面修复的研究进展 ", 《南通大学学报(医学版)》 *
曹美田等: "碘伏消毒液与丹参粉针剂联合外用治疗压疮感染性创面疗效研究 ", 《中国执业药师》 *
郭琦: "水胶体敷料结合丹参酮注射液湿敷治疗慢性伤口的疗效观察", 《中华护理教育》 *
黄韫: "丹参静滴联合湿敷治疗下肢静脉曲张溃疡 ", 《中国医药指南》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110251716A (zh) * 2019-04-22 2019-09-20 张贤慧 一种伤口护理用凝胶敷料及其制备方法
CN110251716B (zh) * 2019-04-22 2020-12-18 张贤慧 一种伤口护理用凝胶敷料及其制备方法
TWI750705B (zh) * 2020-06-19 2021-12-21 慈濟學校財團法人慈濟大學 預防及/或治療壓力誘發疾病之方法

Also Published As

Publication number Publication date
EP3226879A1 (en) 2017-10-11
GB2538580B (en) 2019-07-24
JP2017537163A (ja) 2017-12-14
GB2538580A (en) 2016-11-23
JP6829691B2 (ja) 2021-02-10
US20180228858A1 (en) 2018-08-16
WO2016087810A1 (en) 2016-06-09
GB201521166D0 (en) 2016-01-13
GB201421479D0 (en) 2015-01-14

Similar Documents

Publication Publication Date Title
Rajasekaran et al. The effect of finger millet feeding on the early responses during the process of wound healing in diabetic rats
EP1100516B1 (en) Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
US20030003170A1 (en) Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
JP2010006708A (ja) 皮膚外用剤、美白剤、抗老化剤および抗酸化剤
US20230055582A1 (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
EP1845935B1 (fr) Utilisation de la silymarine et/ou de ses constituants comme agents promoteur de la pigmentation de la peau ou des cheveux
US20140086977A1 (en) Tight junctions modulators
GB2538580B (en) A plant extract and compounds for use in wound healing
FR3075642A1 (fr) Extrait de fleurs de kapokier et compositions cosmetiques, pharmaceutiques ou dermatologiques le comprenant
WO2017129779A1 (fr) Compositions cosmetiques, dermatologiques comprenant un extrait de vitex negundo enrichi en polyphenols
Kim et al. A literature review of bioactive substances for the treatment of periodontitis: In vitro, in vivo and clinical studies
KR20170047514A (ko) 그라비올라 항균 추출물을 함유하는 피부 주름 개선용 마스크 화장료 조성물 및 그 제조방법
Sudsai et al. Wound healing properties of pharmaceutical gel containing isopimarane diterpene isolated from Kaempferia galanga L.
CA3179281A1 (fr) Hydrolysat de proteines du tourteau des graines de moringa peregrina pour son application en tant que medicament, son procede d'obtention et compositions pharmaceutiques et dermatologique
KR102475898B1 (ko) 그라비올라 항균 추출물을 함유하는 화장료 조성물 및 그 제조방법
FR3031458B1 (fr) Extraits de salade, compositions et utilisations
WO2022157457A1 (fr) Extrait de parties aeriennes de basilic sacre et compositions cosmetiques, ou dermatologiques le comprenant
KR102079090B1 (ko) 적하수오 줄기 추출물을 함유하는 기능성 화장품 조성물
KR100771523B1 (ko) 테레인을 포함하는 피부 각질 형성세포 증식 억제제
Tsaffo et al. Evaluation of Infected and Non-infected Wounds Healing Activity of Eriosema robustum Hydroethanolic Leaves Extract Ointments in Streptozotocin Induced Diabetic Rats
KR20250046070A (ko) 피부 상태 개선용 조성물
Madoui et al. Anti-inflammatory and healing effect of leaf-flower mixture extract of Cytisus triflorus L.
KR101434446B1 (ko) 참그물바탕말을 이용한 피부 외용제 조성물
Pampattiwar et al. Selection of medicinal plants for the management of diabetic foot ulcer; an ayurvedic approach
TW201701895A (zh) 基質金屬蛋白酶產生抑制劑

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170905

RJ01 Rejection of invention patent application after publication